Optimizing use of multi-antibody assays for Lyme disease diagnosis: A bioinformatic approach.

Multiple different recombinant and peptide antigens are now available for serodiagnosis of Lyme disease (LD), but optimizing test utilization remains challenging. Since 1995 the Centers for Disease Control and Prevention (CDC) has recommended a 2-tiered serologic approach consisting of a first-tier...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Richard Porwancher, Lisa Landsberg
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/75ac4a0f062f493f9a23a39e4c34413c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!